Format

Send to

Choose Destination
J Nucl Med. 2008 Nov;49(11):1735-8. doi: 10.2967/jnumed.108.053041. Epub 2008 Oct 16.

Peptide-based probes for cancer imaging.

Author information

1
University of Berne, Berne, Switzerland. reubi@pathology.unibe.ch

Abstract

Receptors for regulatory peptides are overexpressed in a variety of human cancers. They represent the molecular basis for in vivo imaging with radiolabeled peptide probes. Somatostatin-derived tracers, designed to image the sst2-overexpressing neuroendocrine tumors, have enjoyed almost 2 decades of successful development and extensive clinical applications. More recent developments include second- and third-generation somatostatin analogs, with a broader receptor subtype profile or with antagonistic properties. Emerging tracers for other peptide receptors, including cholecystokinin/gastrin and GLP-1 analogs for neuroendocrine tumors, bombesin and neuropeptide-Y analogs for prostate or breast cancers, or Arg-Gly-Asp peptides for neoangiogenesis labeling, are also in current development. Application fields include both SPECT/CT and PET/CT.

PMID:
18927341
DOI:
10.2967/jnumed.108.053041
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center